Target intelligence / Profile preview

Cyclooxygenase peroxidase site

Molecular classification
Enzyme, Peroxidase (heme-containing oxidoreductase family)
01

Overview

The **cyclooxygenase peroxidase site** refers to the peroxidase active site of prostaglandin-endoperoxide synthase enzymes, commonly known as **cyclooxygenases** (COX-1 and COX-2). This heme-containing enzymatic site is spatially distinct from, but functionally coupled to, the cyclooxygenase site within the same enzyme molecule[1][5][8]. The peroxidase site plays an essential role in the biosynthetic conversion of arachidonic acid to prostaglandins by catalyzing the reduction of hydroperoxide intermediates (such as PGG₂ to PGH₂), a critical step in the formation of bioactive lipids involved in inflammation, pain, cancer, and cardiovascular disease[1][2][8]. The peroxidase activity is required for full cyclooxygenase activation, as activation of the heme at the peroxidase site initiates the radical catalysis in the cyclooxygenase active site[1][3][5]. Both sites are targets of nonsteroidal anti-inflammatory drugs (NSAIDs), though most NSAIDs primarily act on the cyclooxygenase site, with some influence (depending on the drug) on peroxidase function as well[4][5]. The peroxidase site is also an area of interest for the development of drugs that modulate prostaglandin synthesis for anti-inflammatory, analgesic, and anti-cancer therapy, with notable therapeutic and safety considerations in chronic use[4][5][8].

Other names
Cyclooxygenase POX siteCOX peroxidase siteCOX POX sitePeroxidase site of prostaglandin-endoperoxide synthase
02

Mechanism of action

Inhibition of prostaglandin synthesis via interruption of peroxide reduction. Direct inhibition or covalent modification of the peroxidase or cyclooxygenase function (aspirin acetylates key serine in cyclooxygenase site, but both sites are functionally linked).

03

Biological functions

Prostaglandin biosynthesisCatalysis of peroxide reductionRegulation of inflammatory response
04

Disease associations

InflammationCancerCardiovascular disease
05

Safety considerations

Gastrointestinal toxicityCardiovascular risk (especially with COX-2 selective inhibitors)Bleeding risk
06

Interacting drugs

Nonsteroidal anti-inflammatory drugs (NSAIDs)

6 more in the full profile.

07

Biomarkers

Prostaglandin levels (e.g., PGE2)Downstream prostaglandin metabolites

Beyond the preview

Go deeper on Cyclooxygenase peroxidase site.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclooxygenase peroxidase site.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call